Muscle abnormalities worsen after post-exertional malaise in long COVID.
Appelman, Brent, Charlton, Braeden T, Goulding, Richie P et al. · Nature communications · 2024 · DOI
Quick Summary
This study looked at muscle tissue changes in long COVID patients, particularly focusing on post-exertional malaise (PEM)—the worsening of fatigue and pain after activity. Researchers found that muscles in long COVID patients showed structural damage, metabolic problems, and unusual deposits that got worse after activity triggered PEM. These findings help explain why exertion makes symptoms worse in some long COVID patients.
Why It Matters
This research provides biological evidence for post-exertional malaise, a hallmark symptom of ME/CFS and long COVID that many patients experience but has lacked clear mechanistic explanation. Understanding muscle-level pathology could inform future diagnostic tests and targeted treatments. The findings validate patient experiences of symptom worsening after exertion with measurable physiological changes.
Observed Findings
Skeletal muscle structure was associated with lower exercise capacity in long COVID patients compared to controls.
Local and systemic metabolic disturbances were present in patient muscles and worsened after PEM induction.
Exercise-induced myopathy (muscle damage from exertion) was documented in patient muscle tissue.
Amyloid-containing deposits accumulated in skeletal muscle tissue of long COVID patients.
These muscle abnormalities demonstrated measurable worsening following post-exertional malaise triggers.
Inferred Conclusions
Post-exertional malaise in long COVID involves specific pathological changes in skeletal muscle that can be objectively measured.
Metabolic dysfunction and abnormal protein aggregation in muscle tissue contribute to exercise intolerance in long COVID.
Post-exertional malaise represents more than functional deconditioning—it involves progressive muscle pathology.
These muscle-level mechanisms may be shared across post-infectious conditions causing similar post-exertional symptoms.
Remaining Questions
Do the amyloid deposits and myopathy resolve with treatment, or do they persist long-term?
What This Study Does Not Prove
This study does not prove that muscle pathology is the sole cause of PEM—other systems (neurological, immune, mitochondrial) may also contribute. The case-control design cannot establish whether the observed muscle changes are a cause or consequence of reduced exercise capacity. The findings are correlational and require validation in larger, prospective studies before clinical application.